New IHE Article on the Cost-Effectiveness of Pneumococcal Vaccines
July 26, 2010
IHE pharmacoeconomic evaluation of 10- and 13- valent pneumococcal vaccines now published in Vaccine.
Article finds that vaccines with increasing serotype coverage are more cost effective when considering the effects of both direct protection and herd immunity.
Chuck AW, Jacobs P, Tyrrell G, Kellner JD. Pharmacoeconomic evaluation of 10- and 13- valent pneumococcal conjugate vaccines. Vaccine 2010; 28: 5485-5490

Institute
of Health Economics